Personal Finance & Investing Information
Most Current BMY news
Intelligent Investing News Intelligent Investing News Why You Just Got Hammered Does Bristol-Meyers Squibb Pass Buffett's Test? 5-Star Stocks Poised to Pop: Gilead Sciences Vaccines Will Turn You Into a Zombie According to Viral Rap Video [video] More Hostile Biotech, Pharma Deals The 7 Most Popular High Yielders in Pharma Checking for Revenue Tricks at Talecris Biotherapeutics Holdings Fatter Wallet. Up 22%. Still Risky. Are You Satisfied With These Margins? Chart Watch: Minyanville Buzz Charts [at Minyanville] - The most-discussed charts on Minyanville's Buzz & Banter. The 15 Highest-Yielding Pharma & Biotech Stocks 15 Dividend-Paying Rally Stocks With Attractive Valuations September's BioPharma Catalyst Calendar Lupus study suggests blood-thinner drugs may help The Woman Who Stops Patients From Killing Themselves Sanofi Ups The Pressure On Genzyme A.M. Vitals: Genzyme Says Sanofi Needs to Cough Up More Cash Pipeline Review: Bristol-Myers Squibb's 5 Keys to Success The Fight for Market Share in Blood Thinners Is On New Rivals to Warfarin as Blood Clot Preventer Intelligent Investing News Intelligent Investing News Celldex is cheap but risky. (Source: The Motley Fool) Discover one of the Oracle of Omaha's favorite ways to size up a stock. (Source: The Motley Fool) Market-trouncing returns could be written in these five stars. (Source: The Motley Fool) You may be surprised. (Source: The Motley Fool) Look here for a clue. (Source: The Motley Fool) Orexigen gets a mirror image of Arena's obesity drug deal. (Source: The Motley Fool) Keep your eye on margins. (Source: The Motley Fool) Evaluating the sustainability of dividend payments. (Source: The Motley Fool) A.M. Vitals: Genzyme Says Sanofi Needs to Cough Up More Cash (Source: WSJ.com) Here's its post-Plavix plan. (Source: The Motley Fool) Non-inferiority trials may be inferior. (Source: The Motley Fool) Just be careful; there's a reason they're high. (Source: The Motley Fool) H-P, Intel and Cisco Slide in August (Source: WSJ.com) Drugs Show Promise to Prevent Clots (Source: WSJ.com) Exelixis Officers Accumulate Stock (Source: WSJ.com)
